Managing Dementia-Related Behavior in the Community

Mort, Jane R.; Tasler, Mary K.

doi:10.1016/s1086-5802(16)30048-1

Cited by 4 publications

(1 citation statement)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Jane R. et al said it is important that a pharmacist educates the care-giver of the cognitively impaired patient [32], and this research suggested the possibility that "education to have you understand the symptoms of cognitive impairment" was effective.…”

Section: Discussionmentioning

confidence: 99%

Factors Related to Medication Adherence of Cognitively Impaired Patients in Community Pharmacies

Nanaumi¹,

Onda²,

Mukai³

et al. 2012

View full text Add to dashboard Cite

Objective: The objective of the study was to identify factors related to donepezil medication adherence ("adherence") of cognitively impaired patients in community pharmacies. Methods: One hundred and twenty community pharmacies in 28 regions in Japan were randomly selected. Questionnaires were mailed to these pharmacies. The pharmacists answered based on the medication profiles ("YAKUREKI") of the patients given donepezil at their pharmacies. The survey items were "adherence", "who is the key person" and ‘the key person’s understanding and awareness of donepazil and its symptoms. The χ2 test and decision tree modeling analysis were performed to examine factors affecting adherence. A 5% level of statistical significance was used in the χ2 test. Results: Questionnaires with data on 479 patients were returned. The most common level of adherence was “take as instructed” (81.2%), followed by “forget once or twice a week” (10.2%). The χ2 test revealed that adherence was good if "key person" was professional caretaker (P = 0.004). Also, adherence was better if key person understood medication about dosage, P < 0.001; effect, P = 0.002; and general side effects,, P < 0.001. According to decision tree analysis, the key person had the strongest relationship with adherence. Conclusions: It was confirmed that the key person’s understanding of the medication and symptoms of cognitive impairment are related to adherence. In particular, it was suggested that there is a strong relationship between the key person and adherence and that factors related to adherence differ according to who the key person is. It is essential in the treatment of cognitive impairment to accurately identify the "key person", in order to provide better pharmaceutical care in community pharmacies

show abstract

Section: Discussionmentioning

confidence: 99%

Factors Related to Medication Adherence of Cognitively Impaired Patients in Community Pharmacies

Nanaumi¹,

Onda²,

Mukai³

et al. 2012

View full text Add to dashboard Cite

show abstract

Aromatic N-Haloazoles

Pevzner

1999

Advances in Heterocyclic Chemistry

View full text Add to dashboard Cite

Effectiveness of Pharmacists' Comprehensive Assessment of Medication Profiles in Dementia Patients

et al. 2015

View full text Add to dashboard Cite

In Japan the prevalence of dementia has increased considerably, and pharmacists are involved in addressing these patients' medication-related problems. Here, we determined whether pharmacists' comprehensive assessment of medication proˆles could reduce the burden of dementia patients' medication-related problems. In this historical cohort study 120 community pharmacies were randomly selected, and participating pharmacists completed questionnaires concerning comprehensive assessment of patient medication proˆles, using a``start'' questionnaire for patients prescribed medication prior to or during the study period and a``follow-up'' questionnaire for patients who subsequently visited pharmacies for prescriptions. Numbers and details of problems and solutions implemented by pharmacists and identiˆed in the start and follow-up questionnaires were compared. Changes in start and follow-up scores were also compared between patients whose problems were identiˆed by pharmacists (identiˆed group) and those whose problems were not (nonidentiˆed group). Data were collected for 349 patients issued medication by 60 pharmacies. The most common medication-related problems identiˆed in the start survey were key person's understanding of donepezil (60 cases) and other dementia treatments (60 cases), and adherence to treatment (53 cases). Solutions implemented by pharmacists included gathering information regarding drug administration and dementia awareness from the key person and providing pharmaceutical counseling and instruction. Subsequently, problems related to understanding of dementia treatment, understanding donepezil, and adherence were resolved by 70.0％, 65.0％, and 58.5％, respectively. Pharmacists' comprehensive assessment of medication proˆles could eŠectively solve dementia patients' medication-related problems.

show abstract

Managing Dementia-Related Behavior in the Community

Cited by 4 publications

References 25 publications

Factors Related to Medication Adherence of Cognitively Impaired Patients in Community Pharmacies

Factors Related to Medication Adherence of Cognitively Impaired Patients in Community Pharmacies

Aromatic N-Haloazoles

Effectiveness of Pharmacists' Comprehensive Assessment of Medication Profiles in Dementia Patients

Contact Info

Product

Resources

About